News from our innovation centres
Get up-to-date with our latest news and discover how other founders have flourished by reading our case studies.
See our sister site the Wood Centre for Innovation for more latest news.
A dynamic new biotech started by Dr David Llewellyn and Dr Joe Illingworth, DJS Antibodies is pioneering the development of novel therapeutics to treat the world’s most critical inflammatory diseases, a class of disease that accounts for more than 50% of deaths worldwide.
We spoke to Peter Hamley, Chief Scientific Officer of amazing biotech start-up Samsara Therapeutics, who have just moved into the new life science labs at our Wood Centre for Innovation.
We spoke to Adam Forsyth CTO of TZ, an Australian start-up at the forefront of electronic locking device development and one of our newer residents at the Oxford Centre for Innovation.
CardMedic must go down as one of the fastest digital start-ups of all time: it went from concept to launch in just 72 hours and this month has signed its first agreement with Kent Surrey Sussex Air Ambulance Trust.
HEAD-TO-HEAD WITH KATIE BEDBOROUGH OF OXFORD VR
Vitaccess have been based here at Oxford Centre for Innovation (OCFI) for nearly two years and, during that time, have seen steep growth. Read on and meet Vitaccess’ CEO and founder, Dr Mark Larkin.
Consultant Connect, a second-floor resident of OCFI, has developed a business idea that is dramatically reducing NHS costs. We spoke to Clare Lerway, Account Manager, to find out more…
One of the OCFI’s longer-term residents, Mirada Medical is a global brand in advanced medical imaging software, mainly for cancer but for some other diseases too. We spoke to their dynamic CEO, Hugh Bettesworth to find out more.
Absolute Antibody and Kerafast Merge to Increase Access to Unique Reagents and Recombinant Antibody Technology […]